Panbela Therapeutics PBLA Stock
Panbela Therapeutics Price Chart
Panbela Therapeutics PBLA Financial and Trading Overview
| Panbela Therapeutics stock price | 0.59 USD |
| Previous Close | 1.16 USD |
| Open | 1.17 USD |
| Bid | 0 USD x 1400 |
| Ask | 0 USD x 1400 |
| Day's Range | 1.17 - 1.24 USD |
| 52 Week Range | 1.16 - 384 USD |
| Volume | 13.56K USD |
| Avg. Volume | 873.28K USD |
| Market Cap | 3.55M USD |
| Beta (5Y Monthly) | 0.813278 |
| PE Ratio (TTM) | 0.006531679 |
| EPS (TTM) | -316.52 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 23.5 USD |
PBLA Valuation Measures
| Enterprise Value | 1.77M USD |
| Trailing P/E | 0.006531679 |
| Forward P/E | -0.36923078 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 0.6528836 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | N/A |
Trading Information
Panbela Therapeutics Stock Price History
| Beta (5Y Monthly) | 0.813278 |
| 52-Week Change | N/A |
| S&P500 52-Week Change | N/A |
| 52 Week High | 384 USD |
| 52 Week Low | 1.16 USD |
| 50-Day Moving Average | 1.49 USD |
| 200-Day Moving Average | 23.57 USD |
PBLA Share Statistics
| Avg. Volume (3 month) | 873.28K USD |
| Avg. Daily Volume (10-Days) | 25.95K USD |
| Shares Outstanding | 2.96M |
| Float | 2.72M |
| Short Ratio | 1.08 |
| % Held by Insiders | 0.86% |
| % Held by Institutions | 4.42% |
| Shares Short | 106.01K |
| Short % of Float | 3.59% |
| Short % of Shares Outstanding | 3.58% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | June 30, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -93.59% |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | -20089000 USD |
| Diluted EPS (ttm) | 183.72 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 7.21M USD |
| Total Cash Per Share (mrq) | 2.44 USD |
| Total Debt (mrq) | 5.19M USD |
| Total Debt/Equity (mrq) | 108.16 USD |
| Current Ratio (mrq) | 1.024 |
| Book Value Per Share (mrq) | 1.838 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -22088000 USD |
| Levered Free Cash Flow (ttm) | -9198750 USD |
Profile of Panbela Therapeutics
| Country | United States |
| State | MN |
| City | Waconia |
| Address | 712 Vista Boulevard |
| ZIP | 55387 |
| Phone | 952-479-1196 |
| Website | https://www.panbela.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 6 |
Panbela Therapeutics, Inc., a clinical-stage biopharmaceutical company, together with its subsidiaries, develops disruptive therapeutics for the treatment of patients with cancer. The company's lead product candidates are Ivospemin (SBP-101), which has completed Phase Ia/Ib clinical trial for the treatment of patients with metastatic pancreatic ductal adenocarcinoma; FlynpoviTM, a combination of eflornithine (CPP-1X) and sulindac; and Eflornithine, an enzyme-activated irreversible inhibitor of the enzyme ornithine decarboxylase. It has a research agreement with the Johns Hopkins University School of Medicine for the development of ivospemin (SBP-101). The company was formerly known as Sun BioPharma, Inc. and changed its name to Panbela Therapeutics, Inc. in December 2020. Panbela Therapeutics, Inc. was incorporated in 2011 and is based in Waconia, Minnesota.
Q&A For Panbela Therapeutics Stock
What is a current PBLA stock price?
Panbela Therapeutics PBLA stock price today per share is 0.59 USD.
How to purchase Panbela Therapeutics stock?
You can buy PBLA shares on the Other OTC exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Panbela Therapeutics?
The stock symbol or ticker of Panbela Therapeutics is PBLA.
Which industry does the Panbela Therapeutics company belong to?
The Panbela Therapeutics industry is Biotechnology.
How many shares does Panbela Therapeutics have in circulation?
The max supply of Panbela Therapeutics shares is 4.85M.
What is Panbela Therapeutics Price to Earnings Ratio (PE Ratio)?
Panbela Therapeutics PE Ratio is now.
What was Panbela Therapeutics earnings per share over the trailing 12 months (TTM)?
Panbela Therapeutics EPS is -316.52 USD over the trailing 12 months.
Which sector does the Panbela Therapeutics company belong to?
The Panbela Therapeutics sector is Healthcare.
Panbela Therapeutics PBLA included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 16175.09 USD — |
-1.62
|
3.94B USD — | 16125.33 USD — | 16341.46 USD — | — - | 3.94B USD — |
| NASDAQ HealthCare IXHC | 958.68 USD — |
-2.07
|
— — | 954.08 USD — | 972.42 USD — | — - | — — |
- {{ link.label }} {{link}}